Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07373093 · ClinicalTrials.gov registry record
Predictors of Measles Vaccine Hesitancy in New York State
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 99
- Enrollment target
NCT07373093: Completed study, sponsored by Albany Medical College.
NCT07373093 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07373093 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
Under-immunization rates for childhood immunizations in the United States range from 8-20%. Previous studies have demonstrated that pediatric patients are most likely to be under-immunized for seasonal immunizations. The aim of this study is to explore the factors and facilitators contributing to measles immunization hesitancy. A secondary aim is to explore the impact of hypothetical contexts on measles immunization hesitancy. The results of this study may identify potential disparities in measles immunization coverage and potential solutions for addressing those disparities.
Primary Outcome
Caregiver intent to vaccinate their child against measles, measured using a single survey item with categorical responses ("yes," "unsure," "probably not," or "definitely not") and reported as the proportion of caregivers classified as intent ("yes") versus non-intent ("unsure," "probably not," or "definitely not") at baseline.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2025-11-04 |
What the finished NCT07373093 record still lists
NCT07373093 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT07373093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07373093 about?
NCT07373093 is a clinical study titled "Predictors of Measles Vaccine Hesitancy in New York State". Under-immunization rates for childhood immunizations in the United States range from 8-20%. Previous studies have demonstrated that pediatric patients are most likely to be under-immunized for seasonal immunizations. The aim of this study is to explore the factors and facilitators contributing to me...
What is the current status of trial NCT07373093?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2025-07-01. Estimated completion is 2025-11-04.
What interventions are being tested in trial NCT07373093?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT07373093?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI